CYDY
CytoDyn Inc.
Key Financials
Net Income
$3.7M
↑ 107.5%
Revenue
$0
↓ 100.0%
Gross Profit
$213000
0.0%
Operating Income
$9.7M
↑ 153.5%
Total Assets
$18.0M
↑ 62.1%
Total Liabilities
$114.1M
↓ 10.8%
Shareholders' Equity
$-96042000.00
↑ 17.7%
EPS (Diluted)
$0.00
↑ 100.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| D | 5/11/2026 | View on SEC |
| 8-K | 4/30/2026 | View on SEC |
| S-1 | 4/22/2026 | View on SEC |
| 424B3 | 4/8/2026 | View on SEC |
| 10-Q | 4/8/2026 | View on SEC |
| 424B3 | 3/25/2026 | View on SEC |
| 4 | 3/24/2026 | View on SEC |
| 4 | 3/24/2026 | View on SEC |
| 4 | 3/24/2026 | View on SEC |
| 4 | 3/24/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CYDY |
| Company Name | CytoDyn Inc. |
| CIK | 1175680 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0531 |
| State of Incorporation | DE |
| Phone | 360-980-8524 |